OnKure Therapeutics, Inc. OKUR
2.90
(0.03)
(1.02%)
as of 25 Sep
- Market cap
- $118.7M
- P/E
- 0.0×
Follow OKUR
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
11.45 | 10.28 | 13.78 | 26.75 |
Net Debt/EBITDA |
4.60 | 4.24 | 12.46 | 10.56 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.89 | 0.85 | 0.85 | 0.67 | |
Capex/Depreciation |
(0.03) | (0.04) | (0.02) | (0.02) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.96) | (0.85) | (0.95) | (0.21) | |
Cash per Share |
5.20 | 4.37 | 14.05 | 3.54 | |
Shareholders Equity per Share |
4.91 | 4.16 | 13.48 | 3.45 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
4.91 | 4.16 | 13.48 | 3.45 | |
Free Cash Flow |
(13.04) | (11.52) | (12.94) | (10.36) | |
Working Capital |
65.28 | 54.92 | 183.15 | 171.03 | |
Capital Expenditures |
(0.01) | (0.01) | 0.00 | 0.00 | |
Net Current Asset Value |
65.12 | 54.91 | 183.14 | 170.43 | |
| Other line items | |||||
Quick Ratio |
11.26 | 9.97 | 13.41 | 26.55 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.96) | (0.85) | (0.95) | (0.21) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
0.76 | 2.20 | 6.68 | 2.19 | |
Average Assets |
75.24 | 88.51 | 149.29 | 132.71 | |
Average Common Equity |
70.22 | 80.01 | 137.50 | 125.14 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates